Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin in Disorder of Consciousness After Stroke
NCT04913831Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Jun 2021
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in disorder of consciousness (DOC) comparing Cerebrolysin Arm with Placebo Arm (2 arms). Primary endpoint: Coma Recovery Scale-Revised at 11 weeks. Status: unknown.
02
Drugs
cerebrolysin
03
Conditions
disorder of consciousness (DOC)
Beyond the preview
Go deeper on NCT04913831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04913831.